Novel Corona Virus Disease 2019 (COVID-19) continue to sweep various nations causing more than 4.5 million confirmed cases and close to 300,000 deaths. Current pharmacotherapy largely fall short of controlling the pandemic. In this letter, we critically appraise the hydroxychloroquine plus azithromycin regimen recommended by Gautret et al and provide rationale for new treatments.